Supplementary Figure S1 from Selective Inhibition of ErbB2-Overexpressing Breast Cancer &lt;i&gt;In vivo&lt;/i&gt; by a Novel TAT-Based ErbB2-Targeting Signal Transducers and Activators of Transcription 3–Blocking Peptide